News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
139 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Novo Nordisk A/S: Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons on 5 February 2018
The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.
February 7, 2018
·
1 min read
BioCapital
OpGen Announces Closing of $12M Public Offering
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
February 7, 2018
·
4 min read
Policy
SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox
If approved, TPOXX would be the first treatment for smallpox.
February 7, 2018
·
4 min read
Business
Theratechnologies Announces Financial Results for Fiscal Year 2017
Record revenue from net sales of $42.8 million, up 16% from previous year.
February 7, 2018
·
15 min read
BioMidwest
Myriad’s myRisk Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation
The key finding is that more than 12 percent of men with prostate cancer had an inherited (i.e. hereditary) mutation in a cancer-causing gene.
February 7, 2018
·
9 min read
Business
Battelle Names Sharon Collinge as New Director and Chief Scientist for National Ecological Observatory Network
Noted ecological expert Sharon K. Collinge was recently selected as the Observatory Director and Chief Scientist for NEON, Battelle announced today.
February 7, 2018
·
2 min read
Business
Kamada Reports Financial Results for Fourth Quarter and Full-Year 2017
Total revenues were $102.8 million, a 33% increase from the $77.5 million recorded in 2016.
February 7, 2018
·
2 min read
BioCapital
Dilon Technologies Announces the Launch of the New CoPilot VL+ Video Laryngoscope
The new CoPilot VL+ boasts a larger, brighter, higher resolution display along with powerful LEDs to help the user obtain a better view of the airway.
February 7, 2018
·
2 min read
Business
Notice to the Annual General Meeting of Orion Corporation – Feb. 7, 2018
Orion Corporation net sales in 2017 totalled EUR 1,085 million (EUR 1,074 million in 2016).
February 7, 2018
·
63 min read
Drug Development
Saniona Completes Recruitment in Phase I Study With New Tesomet tablet
The trial is comprised of a total of 60 volunteers.
February 7, 2018
·
2 min read
Previous
3 of 14
Next